Author:
Zhang Qingzhao,Chai Hao,Liang Weijuan,Ma Shuangge
Abstract
AbstractFor complex diseases, beyond the main effects of genetic (G) and environmental (E) factors, gene-environment (G-E) interactions also play an important role. Many of the existing G-E interaction methods conduct marginal analysis, which may not appropriately describe disease biology. Joint analysis methods have been developed, with most of the existing loss functions constructed based on likelihood. In practice, data contamination is not uncommon. Development of robust methods for interaction analysis that can accommodate data contamination is very limited. In this study, we consider censored survival data and adopt an accelerated failure time (AFT) model. An exponential squared loss is adopted to achieve robustness. A sparse group penalization approach, which respects the “main effects, interactions” hierarchy, is adopted for estimation and identification. Consistency properties are rigorously established. Simulation shows that the proposed method outperforms direct competitors. In data analysis, the proposed method makes biologically sensible findings.
Publisher
Springer Nature Singapore
Reference25 articles.
1. Agarwal, A. K., & Garg, A. (2010). Enzymatic activity of the human 1-acylglycerol-3-phosphate-o-acyltransferase isoform 11: upregulated in breast and cervical cancers. Journal of Lipid Research, 51, 2143–2152.
2. Anastas, J., Biechele, T., Robitaille, M., Muster, J., Allison, K., Angers, S., & Moon, R. (2012). A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression. Oncogene, 31, 3696.
3. Bien, J., Taylor, J., & Tibshirani, R. (2013). A lasso for hierarchical interactions. Annals of Statistics, 41, 1111–1141.
4. Bowman, L. (2011). Doctors, researchers worry about accuracy of social security “death file”. http://projects.scrippsnews.com/story/doctors-researchers-worry/. Accessed 30 Apr. 2015
5. Comprehensive molecular profiling of lung adenocarcinoma. (2014). The cancer genome atlas research network. Nature, 511, 543–550.